Andrew Dudum - Mar 20, 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Mar 20, 2024
Transactions value $
-$823,055
Form type
4
Date filed
3/21/2024, 07:08 PM
Previous filing
Mar 19, 2024
Next filing
Apr 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale -$823K -50.4K -100% $16.34 0 Mar 20, 2024 Direct F1, F2
holding HIMS Class A Common Stock 1.6M Mar 20, 2024 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 1.68M Mar 20, 2024 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 419K Mar 20, 2024 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 597K Mar 20, 2024 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 892K Mar 20, 2024 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
holding HIMS Class A Common Stock 1.32M Mar 20, 2024 Held by Trustee of AD 2022 GRAT 3
holding HIMS Class A Common Stock 1.58M Mar 20, 2024 Held by Trustee of AD 2023 GRAT dated 9-5-2023
holding HIMS Class A Common Stock 570K Mar 20, 2024 Held by Trustee of Dudum Family Community Property Trust
holding HIMS Class A Common Stock 1.5K Mar 20, 2024 Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
holding HIMS Class A Common Stock 2.87M Mar 20, 2024 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.86 - $16.575. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.